Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

Progress

Bill Gates: Why Dig Deep Into Alzheimer’s

June 7, 2019 6 Comments

VIDEO + ARTICLE: Bill Gates wrote a $100,000,000 check for Alzheimer’s research. See him share his thoughts on what will it take to find a

Longer Tangles – Alzheimer’s Newest Culprit

April 16, 2019 No Comments

PROGRESS IN THE NEWS: 100 years ago, Dr. Alois Alzheimer’s identified plaques and tangles as the hallmarks of Alzheimer’s. In the search for a cure,

Bill Gates Talks About Our Miraculous Age for Alzheimer’s Diagnostics and What He is Doing About It

April 8, 2019 No Comments

HEAR BILL GATES on why he funds the Alzheimer’s Diagnostics Accelerator. His goal? Earlier and better diagnosis of Alzheimer’s. The $30 million venture philanthropic fund

Cautious Optimism Surrounds Biogen Alzheimer’s Trial

July 15, 2018 No Comments

CLINICAL TRIAL NEWS – VIDEO + ARTICLE: Skeptical Alzheimer’s experts expressed surprising optimism regarding Biogen’s BAN-2401 drug. Dr. Ronald Peterson is one of the world’s

Peter Joins Aducanamab Trial to Fight Alzheimer’s

May 7, 2018 No Comments

TIME MAGAZINE VIDEO: See Peter Wooding and his wife battle Alzheimer’s, 18 months into the Aducanamab Clinical Trial. On FDA’s Fast-Track program, the new vaccine’s

Dementia Decreases Across the USA

November 27, 2016 1 Comment

VIDEO + ARTICLE: Has the prevalence of dementia REALLY changed among older adults in the United States between 2000 and 2012?

Sleep ‘Sweet Spot’ Keeps Brain Sharp

February 6, 2026

Too much sleep and too little sleep can contribute to cognitive decline, researchers report. Learn more.

ai generated, neuron, brain, synapses, biology, science, thinking, cell, anatomy, nerves, neural, mind, dendrites, connection, physiology, neurology

How Lecanemab Clears Amyloid and Slows Alzheimer’s—even as Tau Spreads

February 5, 2026

New early-onset Alzheimer’s data show that lecanemab can slow functional decline—even while tau continues to spread in the brain. The research helps explain how amyloid-lowering treatments may still preserve daily life, despite the disease’s complexity.

Seeing the Same GP Improves Dementia Treatment

February 5, 2026

People with dementia who were consistently seen by the same General Practitioner (GP) are given fewer medicines and are less likely to be given medicines that can cause problems, according to researchers at University of Exeter. Learn more.

Most Popular Stories

My Forgetfulness: Alzheimer’s or Normal Aging?

People worry about becoming forgetful. Is it the first sign of Alzheimer’s or just the passing years? After all, forgetfulness is a normal part of aging. Check out these quick ways to tell the difference.

Financial Problems Can Signal Dementia Onset

Researchers found in a study that people who developed dementia were more likely to have their credit rating drop at least two and a half years before the diagnosis. Some had problems managing their money up to six years before. Find out more.

Curing Alzheimer’s by Fixing Proteins, Not Clearing Them

Scientists say restoring a brain protein, not removing amyloid plaques, should be the target of Alzheimer’s dementia therapies. The researchers said treatment might lie in normalizing the levels of a specific brain protein.

Can Alzheimer’s Be Treated with Iron-Modifying Drugs?

Dietary iron is an essential element in the brain. That’s why it is critical to understand how it affects Alzheimer’s. Researchers used advanced X-ray techniques to take a giant step forward in understanding iron chemistry in amyloid plaque, the main culprit behind Alzheimer’s. Learn more about their exciting new insights.